Morgan Stanley raised the firm’s price target on Confluent (CFLT) to $27 from $25 and keeps an Equal Weight rating on the shares following what the firm calls the company’s “best quarter of 2025.” The firm, which looks for more consistent execution to get “back on board,” adds that the setup into 2026 “doesn’t look as difficult as it did last year.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CFLT:
- Confluent’s Mixed Signals: Hold Rating Amidst Growth and Execution Challenges
- Confluent price target raised to $28 from $27 at Piper Sandler
- Confluent price target raised to $30 from $24 at Wells Fargo
- Confluent price target raised to $27 from $24 at Barclays
- Confluent’s Strong Growth and Strategic Confidence Earns Buy Rating